KMT2D and bladder transitional cell carcinoma: In the TCGA-BLCA cohort, TTN, KMT2D, MUC16, PIK3CA, SYNE1, HMCN1, EP300, MACF1, FLG and ELF3 had higher mutation frequencies in NCOR1-MT patients.